Related Experiment Video
Updated: Jan 20, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
Narsis Attar1,2, Siavash K Kurdistani1,2,3,4
1Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, California 90095.
Abstract:
p300 and CREB-binding protein (CBP), two homologous lysine acetyltransferases in metazoans, have a myriad of cellular functions. They exert their influence mainly through their roles as transcriptional regulators but also via nontranscriptional effects inside and outside of the nucleus on processes such as DNA replication and metabolism. The versatility of p300/CBP as molecular tools has led to their exploitation by viral oncogenes for cellular transformation and by cancer cells to achieve and maintain an oncogenic phenotype. How cancer cells use p300/CBP in their favor varies depending on the cellular context and is evident by the growing list of loss- and gain-of-function genetic alterations in p300 and CBP in solid tumors and hematological malignancies. Here, we discuss the biological functions of p300/CBP and how disruption of these functions by mutations and alterations in expression or subcellular localization contributes to the cancer phenotype.
Insights
p300 and CREB-binding protein (CBP) are crucial for cellular functions, including gene regulation and metabolism. Cancer cells exploit these proteins, with genetic alterations in p300/CBP contributing to various malignancies.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- p300 and CREB-binding protein (CBP) are homologous lysine acetyltransferases with diverse cellular roles.
- These proteins function as transcriptional regulators and impact non-transcriptional processes like DNA replication and metabolism.
- p300/CBP are frequently exploited by oncogenes and cancer cells to promote and sustain oncogenic phenotypes.
Purpose of the Study:
- To discuss the multifaceted biological functions of p300/CBP.
- To elucidate how cancer cells utilize p300/CBP for transformation and maintaining malignancy.
- To review the contribution of p300/CBP alterations to the cancer phenotype.
Main Methods:
- Literature review and synthesis of existing research on p300/CBP.
- Analysis of genetic alterations (mutations, expression changes, localization) in p300 and CBP across various cancers.
- Discussion of functional consequences of these alterations in the context of cancer biology.
Main Results:
- p300/CBP possess extensive transcriptional and non-transcriptional roles critical for normal cellular function.
- Cancer cells leverage p300/CBP activity for cellular transformation and oncogenesis.
- Aberrant p300/CBP function, due to genetic alterations, is a common feature in both solid tumors and hematological malignancies, contributing to cancer development and progression.
Conclusions:
- Disruption of p300/CBP biological functions through genetic alterations significantly contributes to the development and maintenance of cancer.
- Understanding these mechanisms offers potential therapeutic targets for cancer treatment.
- The context-dependent role of p300/CBP in cancer highlights the complexity of targeting these proteins.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

